Literature DB >> 8204336

Attitudes of general practitioners in New Zealand to pharmaceutical representatives.

A N Thomson1, B J Craig, P M Barham.   

Abstract

BACKGROUND: Pharmaceutical representatives are a vital component of the marketing of pharmaceutical products and an important source of prescribing information for general practitioners. AIM: A study was undertaken to explore the attitudes of New Zealand general practitioners to pharmaceutical representatives.
METHOD: A questionnaire survey of 100 general practitioners was undertaken to which 67 general practitioners responded.
RESULTS: The provision of practical prescribing advice by representatives and gifts relevant to medicine were seen as desirable activities by many respondents. However, gifts of value considerably greater than suggested acceptable in recent guidelines for general practitioners were also highly favoured by some practitioners.
CONCLUSION: Current ethical guidelines setting out the relationship between pharmaceutical representatives and medical practitioners are inadequate and should be based on the need for the general practitioner to become an unbiased promoter of patient health.

Entities:  

Keywords:  Empirical Approach; Health Care and Public Health

Mesh:

Year:  1994        PMID: 8204336      PMCID: PMC1238870     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  14 in total

1.  Cognitive consequences of forced compliance.

Authors:  L FESTINGER; J M CARLSMITH
Journal:  J Abnorm Psychol       Date:  1959-03

2.  Knowledge resource preferences of family physicians.

Authors:  D P Connelly; E C Rich; S P Curley; J T Kelly
Journal:  J Fam Pract       Date:  1990-03       Impact factor: 0.493

3.  Principles of educational outreach ('academic detailing') to improve clinical decision making.

Authors:  S B Soumerai; J Avorn
Journal:  JAMA       Date:  1990-01-26       Impact factor: 56.272

Review 4.  A model of methods for influencing prescribing: Part II. A review of educational methods, theories of human inference, and delineation of the model.

Authors:  D W Raisch
Journal:  DICP       Date:  1990-05

5.  Content analysis of drug-detailing by pharmaceutical representatives.

Authors:  E Hemminki
Journal:  Med Educ       Date:  1977-05       Impact factor: 6.251

6.  A model of methods for influencing prescribing: Part I. A review of prescribing models, persuasion theories, and administrative and educational methods.

Authors:  D W Raisch
Journal:  DICP       Date:  1990-04

7.  Getting good value from drug reps.

Authors: 
Journal:  Drug Ther Bull       Date:  1983-02-25

8.  Rational prescribing and sources of information.

Authors:  F Haayer
Journal:  Soc Sci Med       Date:  1982       Impact factor: 4.634

9.  Doctors, drug companies, and gifts.

Authors:  M M Chren; C S Landefeld; T H Murray
Journal:  JAMA       Date:  1989 Dec 22-29       Impact factor: 56.272

10.  Family practice residents' prescribing patterns.

Authors:  M G Jackson; C R Drechsler-Martell; E A Jackson
Journal:  Drug Intell Clin Pharm       Date:  1985-03
View more
  9 in total

1.  General practitioners and pharmaceutical sales representatives: quality improvement research.

Authors:  Geoffrey Spurling; Peter Mansfield
Journal:  Qual Saf Health Care       Date:  2007-08

2.  Analysis of US Food and Drug Administration Warning Letters: False Promotional Claims Relating to Prescription and Over-the-Counter Medications.

Authors:  Maribel Salas; Michelle Martin; Maria Pisu; Erin McCall; Alvaro Zuluaga; Stephen P Glasser
Journal:  Pharmaceut Med       Date:  2008-03-01

3.  Conflict of interest.

Authors:  C Ronald MacKenzie; Bruce N Cronstein
Journal:  HSS J       Date:  2006-09

4.  Japanese practicing physicians' relationships with pharmaceutical representatives: a national survey.

Authors:  Sayaka Saito; Kei Mukohara; Seiji Bito
Journal:  PLoS One       Date:  2010-08-13       Impact factor: 3.240

5.  A survey of pharmaceutical company representative interactions with doctors in Libya.

Authors:  Mustafa A Alssageer; Stefan R Kowalski
Journal:  Libyan J Med       Date:  2012-09-18       Impact factor: 1.657

6.  What do Libyan doctors perceive as the benefits, ethical issues and influences of their interactions with pharmaceutical company representatives?

Authors:  Mustafa Ali Alssageer; Stefan Robert Kowalski
Journal:  Pan Afr Med J       Date:  2013-04-06

7.  Characteristics and impact of drug detailing for gabapentin.

Authors:  Michael A Steinman; G Michael Harper; Mary-Margaret Chren; C Seth Landefeld; Lisa A Bero
Journal:  PLoS Med       Date:  2007-04       Impact factor: 11.069

8.  Validity of tools used for surveying physicians about their interactions with pharmaceutical company: a systematic review.

Authors:  Tamara Lotfi; Rami Z Morsi; Nada Zmeter; Mohammad W Godah; Lina Alkhaled; Lara A Kahale; Hala Nass; Hneine Brax; Racha Fadlallah; Elie A Akl
Journal:  BMC Res Notes       Date:  2015-11-25

Review 9.  Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review.

Authors:  Freek Fickweiler; Ward Fickweiler; Ewout Urbach
Journal:  BMJ Open       Date:  2017-09-27       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.